1. Home
  2. RGF vs LGVN Comparison

RGF vs LGVN Comparison

Compare RGF & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGF
  • LGVN
  • Stock Information
  • Founded
  • RGF 2016
  • LGVN 2014
  • Country
  • RGF United States
  • LGVN United States
  • Employees
  • RGF N/A
  • LGVN N/A
  • Industry
  • RGF Packaged Foods
  • LGVN Medicinal Chemicals and Botanical Products
  • Sector
  • RGF Consumer Staples
  • LGVN Health Care
  • Exchange
  • RGF Nasdaq
  • LGVN Nasdaq
  • Market Cap
  • RGF 9.8M
  • LGVN 7.8M
  • IPO Year
  • RGF 2021
  • LGVN 2021
  • Fundamental
  • Price
  • RGF $0.54
  • LGVN $4.39
  • Analyst Decision
  • RGF Buy
  • LGVN Strong Buy
  • Analyst Count
  • RGF 2
  • LGVN 1
  • Target Price
  • RGF $2.25
  • LGVN $12.00
  • AVG Volume (30 Days)
  • RGF 103.8K
  • LGVN 24.4M
  • Earning Date
  • RGF 08-09-2024
  • LGVN 08-09-2024
  • Dividend Yield
  • RGF N/A
  • LGVN N/A
  • EPS Growth
  • RGF N/A
  • LGVN N/A
  • EPS
  • RGF N/A
  • LGVN N/A
  • Revenue
  • RGF $156,379,000.00
  • LGVN $978,000.00
  • Revenue This Year
  • RGF $23.67
  • LGVN $137.24
  • Revenue Next Year
  • RGF N/A
  • LGVN $50.77
  • P/E Ratio
  • RGF N/A
  • LGVN N/A
  • Revenue Growth
  • RGF 18.88
  • LGVN N/A
  • 52 Week Low
  • RGF $0.21
  • LGVN $0.77
  • 52 Week High
  • RGF $4.70
  • LGVN $37.50
  • Technical
  • Relative Strength Index (RSI)
  • RGF 48.51
  • LGVN 71.83
  • Support Level
  • RGF $0.48
  • LGVN $3.80
  • Resistance Level
  • RGF $0.56
  • LGVN $6.40
  • Average True Range (ATR)
  • RGF 0.05
  • LGVN 0.53
  • MACD
  • RGF -0.01
  • LGVN 0.28
  • Stochastic Oscillator
  • RGF 36.00
  • LGVN 59.31

About RGF The Real Good Food Company Inc.

The Real Good Food Company Inc is an innovative, high-growth, branded, health- and wellness-focused frozen food company. It develops, markets, and manufactures delicious and convenient comfort foods designed to be high in protein, low in sugar, and made from gluten- and grain-free ingredients that are intended to be sold in the health and wellness segment of the frozen food category. All of its revenue is derived from the United States.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: